Offer - Urjas Oil for just ₹ 1 X
Terbinator 125 Tablet (7) is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Fungal Infections, Nail Fungus. Other than this, Terbinator 125 Tablet (7) has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Terbinator 125 Tablet (7). Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Common side effects of Terbinator 125 Tablet (7) include Abdominal Pain, Headache, Flatulence. Some other side effects of Terbinator 125 Tablet (7) have been listed ahead. These side effects of Terbinator 125 Tablet (7) are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Terbinator 125 Tablet (7)'s effect is Safe during pregnancy and Severe for lactating mothers. Further, the section on Terbinator 125 Tablet (7) related warnings talks about Terbinator 125 Tablet (7)'s effects on the liver, heart and kidney.
The section on Terbinator 125 Tablet (7) contraindications lists all such conditions.
Besides this, Terbinator 125 Tablet (7) may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Terbinator 125 Tablet (7) is not safe while driving, and is not addiction.
Terbinator 125 Tablet (7) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Terbinator 125 Tablet (7) safe for pregnant women?
Pregnant women can take Terbinator safely.
Is the use of Terbinator 125 Tablet (7) safe during breastfeeding?
Terbinator should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Terbinator 125 Tablet (7) on the Kidneys?
There may be some adverse effects on kidney after taking Terbinator. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Terbinator 125 Tablet (7) on the Liver?
You may experience side effects on your liver after taking Terbinator. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Terbinator 125 Tablet (7) on the Heart?
You can take Terbinator without any fear of damage to the heart.
Terbinator 125 Tablet (7) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Terbinator 125 Tablet (7) unless your doctor advises you to do so -
Is this Terbinator 125 Tablet (7) habit forming or addictive?
Forming a habit of Terbinator 125 Tablet (7) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Terbinator 125 Tablet (7) can make you feel drowsy.
Is it safe?
Terbinator 125 Tablet (7) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Terbinator 125 Tablet (7) in mental disorders is not effective.
Interaction between Food and Terbinator 125 Tablet (7)
Taking Terbinator 125 Tablet (7) with food does not harm your health.
Interaction between Alcohol and Terbinator 125 Tablet (7)
Information about the interaction of Terbinator 125 Tablet (7) and alcohol is not currently available because this topic has not been researched yet.
Terbinator is a brand name of terbinafine. It is a prescription drug that belongs to the class of medication called antifungal. It is available in a different dosage form such as a tablet, cream, and powder. It is used in the treatment of antifungal infections such as tinea corporis (fungal infection of the skin or scalp known as ringworm), tinea cruris (fungal infection in the skin of the genitals known as Jock itch), tinea pedis (fungal infection between the toes also known as athlete's foot), cutaneous candidiasis (skin and nail fungal infection), tinea versicolor (discolored patches of skin), and vaginal candidiasis (a yeast infection of the vagina).
Yes, Terbinator can sometimes affect the liver by increasing the secretion of liver enzymes which can damage the liver cells. Rare cases of serious hepatotoxicity (liver damage), including liver failure have been reported. Hence a routine liver function test should be conducted when taking this drug for a long time.
Yes, Terbinator is safe to use, if taken in a prescribed amount for a specified time as advised by the doctor, however, few side effects are observed such as stomach discomfort, headache, and hypokalemia (low potassium).
No, Terbinator is not a steroid. It is an antifungal medicine which belongs to the class of drug known as triazoles.
Discontinuation of Terbinator on your own can cause unwanted side effects. You are recommended to always get yourself checked by a doctor to ensure eradication of fungal disease before discontinuing this medicine.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamisil (terbinafine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 795-796
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177